The protein stability of KRAS mutants can influence tumor promotion. Here, the authors identify that deubiquitinase JOSD2 stabilizes KRAS mutants and JOSD2 depletion inhibits KRAS-mutant colorectal cancer growth in part due to mutant KRAS degradation.